• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种美国药典西他列汀杂质的高效简便合成:3-去氨基-2,3-脱水西他列汀和3-去氨基-3,4-脱水西他列汀。

Efficient and Straightforward Syntheses of Two United States Pharmacopeia Sitagliptin Impurities: 3-Desamino-2,3-dehydrositagliptin and 3-Desamino-3,4-dehydrositagliptin.

作者信息

Sova Matej, Frlan Rok, Gobec Stanislav, Časar Zdenko

机构信息

University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, Ljubljana 1000, Slovenia.

Lek Pharmaceuticals, d.d., Sandoz Development Center Slovenia, Verovškova ulica 57, Ljubljana SI-1526, Slovenia.

出版信息

ACS Omega. 2020 Mar 3;5(10):5356-5364. doi: 10.1021/acsomega.9b04393. eCollection 2020 Mar 17.

DOI:10.1021/acsomega.9b04393
PMID:32201825
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7081400/
Abstract

Various organic impurities (starting materials, reagents, intermediates, degradation products, by-products, and side products) could be present in active pharmaceutical ingredients affecting their qualities, safeties, and efficacies. Herein, we present the efficient syntheses of two United States Pharmacopeia impurities of an antidiabetic drug sitagliptin, a potent and orally active dipeptidyl peptidase IV inhibitor: 3-desamino-2,3-dehydrositagliptin and 3-desamino-3,4-dehydrositagliptin. Our three-step synthetic approach is based on the efficient cobalt-catalyzed cross-coupling reaction of 1-bromo-2,4,5-trifluorobenzene and methyl 4-bromocrotonate in the first step, followed by hydrolysis of corresponding ester with 3 M HCl to ()-(2,4,5-trifluorophenyl)but-2-enoic acid in high overall yield, whereas the reaction with 3 M NaOH resulted in the carbon-carbon double bond regio-isomerization and hydrolysis to give the ()-(2,4,5-trifluorophenyl)but-3-enoic acid in 92% yield. Both acid derivatives were converted to title compounds via the amide bond formation with 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-]pyrazine. Extensive screening of coupling/activation reagents, bases, and solvents reviled that the amide bond is formed the most efficiently using the (COCl)/EtN in THF or alternatively EDC/NMM/(DMAP or HOBt) in DMF obtaining the title compounds in 68-76% yields and providing the overall yields for the three-step process in the range of 57-64% on a gram scale. The presented study also demonstrates the importance of a proper selection of solvent, base, and coupling/activating reagent for amide bond formation using Michael acceptor-type allylbenzene derivatives as coupling partners to minimize the carbon-carbon double bond regio-isomerization.

摘要

各种有机杂质(起始原料、试剂、中间体、降解产物、副产物和杂质)可能存在于活性药物成分中,影响其质量、安全性和有效性。在此,我们展示了两种美国药典中抗糖尿病药物西他列汀(一种强效口服活性二肽基肽酶IV抑制剂)杂质的高效合成方法:3-去氨基-2,3-脱氢西他列汀和3-去氨基-3,4-脱氢西他列汀。我们的三步合成方法第一步基于1-溴-2,4,5-三氟苯与4-溴巴豆酸甲酯的高效钴催化交叉偶联反应,随后用3 M盐酸水解相应的酯,以较高的总收率得到()-(2,4,5-三氟苯基)丁-2-烯酸,而与3 M氢氧化钠反应则导致碳-碳双键区域异构化并水解,以92%的收率得到()-(2,4,5-三氟苯基)丁-3-烯酸。两种酸衍生物通过与3-(三氟甲基)-5,6,7,8-四氢-[1,2,4]三唑并[4,3-]吡嗪形成酰胺键转化为目标化合物。对偶联/活化试剂、碱和溶剂进行广泛筛选发现,使用(COCl)/EtN在四氢呋喃中或EDC/NMM/(DMAP或HOBt)在N,N-二甲基甲酰胺中最有效地形成酰胺键,以68-76%的收率得到目标化合物,并在克级规模上提供三步过程的总收率在57-64%范围内。本研究还证明了使用迈克尔受体型烯丙基苯衍生物作为偶联伙伴形成酰胺键时,正确选择溶剂、碱和偶联/活化试剂对于最小化碳-碳双键区域异构化的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df1/7081400/759d66a4fc4e/ao9b04393_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df1/7081400/833bb897a727/ao9b04393_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df1/7081400/baaa676987b7/ao9b04393_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df1/7081400/759d66a4fc4e/ao9b04393_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df1/7081400/833bb897a727/ao9b04393_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df1/7081400/baaa676987b7/ao9b04393_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df1/7081400/759d66a4fc4e/ao9b04393_0002.jpg

相似文献

1
Efficient and Straightforward Syntheses of Two United States Pharmacopeia Sitagliptin Impurities: 3-Desamino-2,3-dehydrositagliptin and 3-Desamino-3,4-dehydrositagliptin.两种美国药典西他列汀杂质的高效简便合成:3-去氨基-2,3-脱水西他列汀和3-去氨基-3,4-脱水西他列汀。
ACS Omega. 2020 Mar 3;5(10):5356-5364. doi: 10.1021/acsomega.9b04393. eCollection 2020 Mar 17.
2
Synthesis of amide derivatives for electron deficient amines and functionalized carboxylic acids using EDC and DMAP and a catalytic amount of HOBt as the coupling reagents.使用1-乙基-3-(3-二甲基氨基丙基)碳二亚胺(EDC)、4-二甲氨基吡啶(DMAP)和催化量的1-羟基苯并三唑(HOBt)作为偶联试剂,合成缺电子胺和功能化羧酸的酰胺衍生物。
Tetrahedron Lett. 2021 Jan 19;63. doi: 10.1016/j.tetlet.2020.152719. Epub 2020 Dec 25.
3
Highly efficient asymmetric synthesis of sitagliptin.西他列汀的高效不对称合成。
J Am Chem Soc. 2009 Jul 1;131(25):8798-804. doi: 10.1021/ja902462q.
4
Comprehensive UHPLC-MS screening methods for the analysis of triazolopyrazine precursor and its genotoxic nitroso-derivative in sitagliptin pharmaceutical formulation.采用 UHPLC-MS 全面筛选方法分析西他列汀药物制剂中的三唑并吡嗪前体及其遗传毒性亚硝胺衍生物。
J Pharm Biomed Anal. 2024 Jan 20;238:115861. doi: 10.1016/j.jpba.2023.115861. Epub 2023 Nov 10.
5
Sitagliptin西他列汀
6
Photocatalytic Activation of Less Reactive Bonds and Their Functionalization via Hydrogen-Evolution Cross-Couplings.通过析氢交叉偶联实现低活性键的光催化活化及其功能化
Acc Chem Res. 2018 Oct 16;51(10):2512-2523. doi: 10.1021/acs.accounts.8b00267. Epub 2018 Oct 3.
7
Synthesis and biological activity of the 2-desamino and 2-desamino-2-methyl analogues of aminopterin and methotrexate.氨甲蝶呤和氨基蝶呤的2-去氨基及2-去氨基-2-甲基类似物的合成与生物活性
J Med Chem. 1991 Jan;34(1):227-34. doi: 10.1021/jm00105a036.
8
Semiconductor Photocatalysis for Chemoselective Radical Coupling Reactions.半导体光催化在选择性自由基偶联反应中的应用。
Acc Chem Res. 2017 Apr 18;50(4):1002-1010. doi: 10.1021/acs.accounts.7b00023. Epub 2017 Apr 5.
9
Atroposelective Synthesis of C-C Axially Chiral Compounds via Mono- and Dinuclear Vanadium Catalysis.通过单核和双核钒催化的 C-C 轴手性化合物的对映选择性合成。
Acc Chem Res. 2022 Oct 18;55(20):2949-2965. doi: 10.1021/acs.accounts.2c00545. Epub 2022 Oct 7.
10
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses.二肽基肽酶IV抑制剂西他列汀在健康受试者中的药代动力学和药效学:两项单次口服剂量随机、双盲、安慰剂对照研究的结果
Clin Pharmacol Ther. 2005 Dec;78(6):675-88. doi: 10.1016/j.clpt.2005.09.002.

引用本文的文献

1
Applications of synthetic biology in medical and pharmaceutical fields.合成生物学在医学和制药领域的应用。
Signal Transduct Target Ther. 2023 May 11;8(1):199. doi: 10.1038/s41392-023-01440-5.
2
Two methods for the preparation of sitagliptin phosphate chemical resolution and asymmetric hydrogenation.磷酸西他列汀的两种制备方法——化学拆分法和不对称氢化法。
RSC Adv. 2021 Jan 25;11(8):4805-4809. doi: 10.1039/d0ra10273c. eCollection 2021 Jan 21.
3
Efficient Synthesis of Potential Impurities in Levonadifloxacin (WCK 771).左氧氟沙星(WCK 771)中潜在杂质的高效合成

本文引用的文献

1
Cu-catalyzed cross-coupling reactions of vinyl epoxide with organoboron compounds: access to homoallylic alcohols.铜催化的环氧乙烯与有机硼化合物的交叉偶联反应:合成高烯丙醇
RSC Adv. 2018 Dec 12;8(72):41561-41565. doi: 10.1039/c8ra09048c. eCollection 2018 Dec 7.
2
Mechanistic Insight into Asymmetric Hetero-Michael Addition of α,β-Unsaturated Carboxylic Acids Catalyzed by Multifunctional Thioureas.多功能硫脲催化α,β-不饱和羧酸不对称杂迈克尔加成反应的机理探究
J Am Chem Soc. 2018 Sep 26;140(38):12216-12225. doi: 10.1021/jacs.8b07511. Epub 2018 Sep 14.
3
Analytical advances in pharmaceutical impurity profiling.
ACS Omega. 2021 Oct 27;6(44):29993-30002. doi: 10.1021/acsomega.1c04639. eCollection 2021 Nov 9.
药物杂质剖析的分析进展。
Eur J Pharm Sci. 2016 May 25;87:118-35. doi: 10.1016/j.ejps.2015.12.007. Epub 2015 Dec 9.
4
Cobalt-Catalyzed Cross-Coupling of Grignards with Allylic and Vinylic Bromides: Use of Sarcosine as a Natural Ligand.钴催化格氏试剂与烯丙基溴和乙烯基溴的交叉偶联反应:使用肌氨酸作为天然配体。
J Org Chem. 2015 Aug 7;80(15):7803-9. doi: 10.1021/acs.joc.5b01156. Epub 2015 Jul 24.
5
Radical-based route to 2-(trifluoromethyl)-1,3,4-oxadiazoles and trifluoromethyl-substituted polycyclic 1,2,4-triazoles and dihydrofurans.基于自由基的路线合成2-(三氟甲基)-1,3,4-恶二唑以及三氟甲基取代的多环1,2,4-三唑和二氢呋喃。
Org Lett. 2015 Mar 20;17(6):1577-80. doi: 10.1021/acs.orglett.5b00457. Epub 2015 Mar 3.
6
Catalytic Enantioselective Allylic Amination of Olefins for the Synthesis of -Sitagliptin.用于合成西他列汀的烯烃催化对映选择性烯丙基胺化反应
Synlett. 2013 Nov 1;24(18):2459-2463. doi: 10.1055/s-0033-1340079.
7
Pharmaceutical impurities and degradation products: uses and applications of NMR techniques.药物杂质与降解产物:核磁共振技术的用途与应用
J Pharm Biomed Anal. 2014 Dec;101:102-22. doi: 10.1016/j.jpba.2014.04.016. Epub 2014 Apr 24.
8
Forced degradation and impurity profiling: recent trends in analytical perspectives.强制降解和杂质剖析:分析视角的最新趋势。
J Pharm Biomed Anal. 2013 Dec;86:11-35. doi: 10.1016/j.jpba.2013.07.013. Epub 2013 Jul 31.
9
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors In the Management of Diabetes.二肽基肽酶-4(DPP-4)抑制剂在糖尿病管理中的应用
P T. 2010 Sep;35(9):509-13.
10
Fast and green microwave-assisted conversion of essential oil allylbenzenes into the corresponding aldehydes via alkene isomerization and subsequent potassium permanganate promoted oxidative alkene group cleavage.通过烯烃异构化以及随后高锰酸钾促进的氧化烯烃基团裂解,将香精油烯丙基苯快速绿色地微波辅助转化为相应的醛。
Molecules. 2009 Sep 3;14(9):3411-24. doi: 10.3390/molecules14093411.